Variant report

Variant	esv2761906
Chromosome Location	chr16:48109727-48125855
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr16:48110275-48111013	HepG2	liver:	n/a	n/a
2	ATF3	chr16:48115465-48115964	A549	lung:	n/a	n/a
3	BATF	chr16:48119687-48119932	GM12878	blood:	n/a	chr16:48119825-48119836
4	CEBPB	chr16:48115796-48115834	K562	blood:	n/a	chr16:48115814-48115827 chr16:48115816-48115825 chr16:48115814-48115825
5	CEBPB	chr16:48110335-48110857	A549	lung:	n/a	n/a
6	CEBPB	chr16:48115736-48115949	MCF-7	breast:	n/a	chr16:48115814-48115827 chr16:48115816-48115825 chr16:48115814-48115825
7	CEBPB	chr16:48110405-48110603	HepG2	liver:	n/a	n/a
8	CEBPB	chr16:48110334-48110880	IMR90	lung:	n/a	n/a
9	CEBPB	chr16:48115657-48115992	HepG2	liver:	n/a	chr16:48115814-48115827 chr16:48115816-48115825 chr16:48115814-48115825
10	CEBPB	chr16:48110217-48111017	A549	lung:	n/a	n/a
11	CEBPB	chr16:48110314-48110795	A549	lung:	n/a	n/a
12	CEBPB	chr16:48115438-48116165	A549	lung:	n/a	chr16:48115814-48115827 chr16:48115816-48115825 chr16:48115814-48115825
13	CEBPB	chr16:48115551-48116037	IMR90	lung:	n/a	chr16:48115814-48115827 chr16:48115816-48115825 chr16:48115814-48115825
14	CEBPB	chr16:48110329-48110900	HepG2	liver:	n/a	n/a
15	CEBPB	chr16:48115560-48116059	A549	lung:	n/a	chr16:48115814-48115827 chr16:48115816-48115825 chr16:48115814-48115825
16	CEBPB	chr16:48115708-48115930	Hela-S3	cervix:	n/a	chr16:48115814-48115827 chr16:48115816-48115825 chr16:48115814-48115825
17	CEBPB	chr16:48115632-48116014	A549	lung:	n/a	chr16:48115814-48115827 chr16:48115816-48115825 chr16:48115814-48115825
18	CREB1	chr16:48115743-48116167	A549	lung:	n/a	n/a
19	CREB1	chr16:48110197-48111009	HepG2	liver:	n/a	n/a
20	CTCF	chr16:48116440-48116590	HBMEC	blood vessel:	n/a	n/a
21	CTCF	chr16:48116000-48116150	HepG2	liver:	n/a	n/a
22	CTCF	chr16:48116040-48116190	AG04449	skin:	n/a	n/a
23	CTCF	chr16:48116020-48116170	AG04449	skin:	n/a	n/a
24	CTCF	chr16:48115760-48115910	AG04449	skin:	n/a	n/a
25	CUX1	chr16:48123580-48123639	GM12878	blood:	n/a	n/a
26	EBF1	chr16:48123499-48123630	GM12878	blood:	n/a	n/a
27	EBF1	chr16:48125309-48125665	GM12878	blood:	n/a	n/a
28	EBF1	chr16:48111216-48111382	GM12878	blood:	n/a	n/a
29	EBF1	chr16:48117323-48117360	GM12878	blood:	n/a	n/a
30	EBF1	chr16:48121683-48121772	GM12878	blood:	n/a	chr16:48121704-48121715 chr16:48121754-48121765
31	ELF1	chr16:48110369-48110617	HepG2	liver:	n/a	n/a
32	EP300	chr16:48123514-48123714	GM12878	blood:	n/a	n/a
33	EP300	chr16:48110421-48110963	HepG2	liver:	n/a	chr16:48110425-48110435
34	EP300	chr16:48115364-48115950	A549	lung:	n/a	chr16:48115917-48115933
35	EP300	chr16:48110238-48111103	A549	lung:	n/a	chr16:48110279-48110293 chr16:48110425-48110435
36	EP300	chr16:48110371-48110802	HepG2	liver:	n/a	chr16:48110425-48110435
37	EP300	chr16:48125486-48125512	GM12878	blood:	n/a	n/a
38	EP300	chr16:48115344-48116032	A549	lung:	n/a	chr16:48115917-48115933
39	EP300	chr16:48110206-48111043	A549	lung:	n/a	chr16:48110279-48110293 chr16:48110425-48110435
40	EP300	chr16:48115480-48115825	SK-N-SH_RA	brain:	n/a	n/a
41	EP300	chr16:48110458-48110854	HepG2	liver:	n/a	n/a
42	EP300	chr16:48115454-48115835	SK-N-SH_RA	brain:	n/a	n/a
43	FOS	chr16:48115484-48115933	MCF10A-Er-Src	breast:	n/a	n/a
44	FOS	chr16:48115484-48115938	MCF10A-Er-Src	breast:	n/a	n/a
45	FOS	chr16:48115511-48115869	MCF10A-Er-Src	breast:	n/a	n/a
46	FOS	chr16:48119821-48119889	MCF10A-Er-Src	breast:	n/a	chr16:48119828-48119837 chr16:48119829-48119838 chr16:48119829-48119837 chr16:48119829-48119836
47	FOS	chr16:48115484-48115917	MCF10A-Er-Src	breast:	n/a	n/a
48	FOS	chr16:48119737-48119926	MCF10A-Er-Src	breast:	n/a	chr16:48119828-48119837 chr16:48119829-48119838 chr16:48119829-48119837 chr16:48119829-48119836
49	FOSL2	chr16:48115305-48115983	A549	lung:	n/a	chr16:48115969-48115980
50	FOSL2	chr16:48115406-48115995	SK-N-SH	brain:	n/a	chr16:48115969-48115980

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr16:48125057-48125107	HCF	heart:	n/a
2	chr16:48116986-48117036	HCF	heart:	n/a
3	chr16:48125057-48125107	SK-N-SH	brain:	n/a
4	chr16:48125057-48125107	HEK293	kidney:	embryo
5	chr16:48116986-48117036	HepG2	liver:	n/a
6	chr16:48116986-48117036	PrEC	prostate:	n/a
7	chr16:48116986-48117036	HL-60	blood:	n/a
8	chr16:48115640-48115690	SKMC	muscle:	n/a
9	chr16:48116986-48117036	GM19239	blood:	n/a
10	chr16:48116986-48117036	H1-hESC	embryonic stem cell:	embryo
11	chr16:48116986-48117036	AG04449	skin:	fetal
12	chr16:48115640-48115690	HCM	heart:	n/a
13	chr16:48115640-48115690	HNPCEpiC	eye:	n/a
14	chr16:48125057-48125107	NHBE	bronchial:	n/a
15	chr16:48116986-48117036	A549	lung:	n/a
16	chr16:48116986-48117036	CMK	blood:	n/a
17	chr16:48125057-48125107	GM12878	blood:	n/a
18	chr16:48125057-48125107	HRCEpiC	kidney:	n/a
19	chr16:48125057-48125107	HNPCEpiC	eye:	n/a
20	chr16:48115640-48115690	GM12878	blood:	n/a
21	chr16:48115640-48115690	AG04450	lung:	fetal
22	chr16:48125057-48125107	HCPEpiC	choroid plexus:	n/a
23	chr16:48115640-48115690	RPTEC	kidney:	n/a
24	chr16:48125057-48125107	CMK	blood:	n/a
25	chr16:48115640-48115690	K562	blood:	n/a
26	chr16:48125057-48125107	IMR90	lung:	fetal
27	chr16:48115640-48115690	GM12891	blood:	n/a
28	chr16:48125057-48125107	SKMC	muscle:	n/a
29	chr16:48116986-48117036	ovcar-3	ovarian:	n/a
30	chr16:48115640-48115690	H1-hESC	embryonic stem cell:	embryo
31	chr16:48115640-48115690	IMR90	lung:	fetal
32	chr16:48116986-48117036	HUVEC	blood vessel:	n/a
33	chr16:48116986-48117036	Caco-2	colon:	n/a
34	chr16:48125057-48125107	PANC-1	pancreas:	n/a
35	chr16:48125057-48125107	NB4	blood:	n/a
36	chr16:48125057-48125107	AG09319	gingival:	n/a
37	chr16:48115640-48115690	HRE	kidney:	n/a
38	chr16:48125057-48125107	HEEpiC	esophagus:	n/a
39	chr16:48125057-48125107	HRE	kidney:	n/a
40	chr16:48125057-48125107	HCM	heart:	n/a
41	chr16:48115640-48115690	GM19239	blood:	n/a
42	chr16:48116986-48117036	NHDF-neo	bronchial:	n/a
43	chr16:48125057-48125107	PFSK-1	brain:	n/a
44	chr16:48125057-48125107	NT2-D1	testis:	n/a
45	chr16:48115640-48115690	Hela-S3	cervix:	n/a
46	chr16:48115640-48115690	SK-N-MC	brain:	n/a
47	chr16:48125057-48125107	AG10803	skin:	n/a
48	chr16:48125057-48125107	HL-60	blood:	n/a
49	chr16:48115640-48115690	Caco-2	colon:	n/a
50	chr16:48125057-48125107	H1-hESC	embryonic stem cell:	embryo

No.	Distal block	Cell Line	Cell type
1	chr16:48117152..48119397-chr16:48143953..48145839,2	K562	blood:
2	chr16:48107738..48109529-chr16:48111849..48114295,2	K562	blood:
3	chr16:48107011..48108589-chr16:48109218..48111502,2	K562	blood:

Variant related genes	Relation type
ABCC12	TF binding region
ABCC12	CpG island

Extended variants
information (count: 596 )
Associated
traits (count: 69 )

Variant overlapped rSNPs/rCNVs (count:596 , 50 per page) page: 1 2 3 4 5 6 7 ... 12

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs141804394	chr16:48109794-48109795	Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs529935917	chr16:48109844-48109845	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
3	rs546631292	chr16:48109868-48109869	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
4	rs566513589	chr16:48109902-48109903	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
5	rs538777070	chr16:48109916-48109917	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs377011077	chr16:48109925-48109926	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs191160214	chr16:48109929-48109930	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs569452992	chr16:48109955-48109956	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
9	rs538016267	chr16:48109957-48109958	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs150588724	chr16:48109977-48109978	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs368497194	chr16:48109985-48109986	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs74905740	chr16:48109990-48109991	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs534477315	chr16:48110024-48110025	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs560489527	chr16:48110035-48110036	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs201667272	chr16:48110062-48110063	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs528422211	chr16:48110100-48110101	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs369497402	chr16:48110106-48110107	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs183283599	chr16:48110127-48110128	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs187455905	chr16:48110148-48110149	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs139572183	chr16:48110155-48110156	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs564786728	chr16:48110163-48110164	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs575397884	chr16:48110186-48110187	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs544124198	chr16:48110301-48110302	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs371992218	chr16:48110302-48110303	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs5816588	chr16:48110344-48110345	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs372749871	chr16:48110366-48110367	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs560740515	chr16:48110396-48110397	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs529971909	chr16:48110413-48110414	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs540504128	chr16:48110415-48110416	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs546468158	chr16:48110439-48110440	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs560137666	chr16:48110454-48110455	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs561799286	chr16:48110517-48110518	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs532339920	chr16:48110531-48110532	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs552652404	chr16:48110557-48110558	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs142785193	chr16:48110581-48110582	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs555610449	chr16:48110624-48110625	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs369130528	chr16:48110651-48110652	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs147383445	chr16:48110660-48110661	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs548531261	chr16:48110677-48110678	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs8048367	chr16:48110683-48110684	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
41	rs567119130	chr16:48110700-48110701	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs534517993	chr16:48110738-48110739	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs191487312	chr16:48110739-48110740	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs183280890	chr16:48110757-48110758	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs187834151	chr16:48110829-48110830	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs376275047	chr16:48110839-48110840	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs376516419	chr16:48110843-48110844	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs369250847	chr16:48110846-48110847	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs533962513	chr16:48110866-48110867	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs61639468	chr16:48110880-48110881	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a

Variant related diseases (count:69)

Disease	PMID	Source
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Autism	19415332	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Schizophrenia	22958593	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Autism	22495311	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Colorectal cancer	16272173	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Wilms tumour	21544195	CNVD
Cancer	20164920	CNVD
Lung cancer	18438408	CNVD
Prostate cancer	18632612	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Breast cancer	17850661	CNVD
Breast cancer	16702952	CNVD
Medulloblastoma	16968546	CNVD
Prostate cancer	19242612	CNVD
Cancer	22429812	CNVD
Ewing''s sarcoma	21437220	CNVD
Ewing''s sarcoma	22429812	CNVD
Melanoma	18172304	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	20837533	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Multiple myeloma	21628407	CNVD
Renal cell carcinoma	18765545	CNVD
Sudden cardiac death	19188705	CNVD
Multiple myeloma	16616336	CNVD
Ovarian cancer	22174824	CNVD
Breast cancer	21858162	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Breast cancer	21364760	CNVD
Ewing''s sarcoma	17952124	CNVD
Myelofibrosis	22110671	CNVD
Attention deficit hyperactivity disorder	21324949	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	21509527	CNVD
Bladder cancer	21909424	CNVD
Colorectal cancer	19359472	CNVD
Olfactory neuroblastoma	18408657	CNVD
Prostate cancer	16461572	CNVD
Breast cancer	17001317	CNVD
Breast cancer	17133270	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Acute lymphoblastic leukemia	18458336	CNVD
Disease	22140031	CNVD
Non-syndromic sensorineural hearing loss	22140031	CNVD
Melanoma	20877625	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD
Prostate cancer	22341455	CNVD

Chromatin state (count:106 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr16:48108800-48112200	Enhancers	Muscle Satellite Cultured Cells	--
2	chr16:48109000-48109800	Enhancers	Osteobl	bone
3	chr16:48109000-48110200	Enhancers	HSMM	muscle
4	chr16:48109000-48110400	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
5	chr16:48109000-48110800	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
6	chr16:48109000-48110800	Enhancers	NHDF-Ad	bronchial
7	chr16:48109000-48111200	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
8	chr16:48109000-48112200	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
9	chr16:48109200-48110600	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
10	chr16:48109200-48110800	Enhancers	NH-A	brain
11	chr16:48109200-48111000	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
12	chr16:48109200-48111000	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
13	chr16:48109400-48111000	Enhancers	HepG2	liver
14	chr16:48109600-48109800	Enhancers	A549	lung
15	chr16:48109800-48110200	Flanking Active TSS	Osteobl	bone
16	chr16:48109800-48110600	Flanking Active TSS	A549	lung
17	chr16:48110000-48110200	Enhancers	Pancreas	Pancrea
18	chr16:48110200-48112200	Enhancers	Osteobl	bone
19	chr16:48110200-48115200	Weak transcription	HSMM	muscle
20	chr16:48110400-48114800	Weak transcription	Foreskin Fibroblast Primary Cells skin01	Skin
21	chr16:48110600-48110800	Enhancers	A549	lung
22	chr16:48110600-48110800	Enhancers	NHLF	lung
23	chr16:48110800-48111800	Weak transcription	A549	lung
24	chr16:48110800-48114200	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
25	chr16:48111000-48115000	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
26	chr16:48111000-48115200	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
27	chr16:48111200-48114400	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
28	chr16:48111800-48112200	Enhancers	A549	lung
29	chr16:48111800-48115200	Weak transcription	NHLF	lung
30	chr16:48112200-48114200	Weak transcription	Muscle Satellite Cultured Cells	--
31	chr16:48112200-48114400	Weak transcription	Osteobl	bone
32	chr16:48112200-48114600	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
33	chr16:48112200-48114800	Weak transcription	A549	lung
34	chr16:48114200-48114400	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
35	chr16:48114200-48116800	Enhancers	Muscle Satellite Cultured Cells	--
36	chr16:48114200-48117200	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
37	chr16:48114400-48115200	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
38	chr16:48114400-48115800	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
39	chr16:48114400-48115800	Enhancers	Osteobl	bone
40	chr16:48114600-48116000	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
41	chr16:48114800-48116400	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
42	chr16:48114800-48116600	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
43	chr16:48114800-48116600	Enhancers	A549	lung
44	chr16:48115000-48116400	Enhancers	HMEC	breast
45	chr16:48115000-48117000	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
46	chr16:48115200-48116400	Enhancers	Psoas Muscle	Psoas
47	chr16:48115200-48116400	Enhancers	Skeletal Muscle Male	skeletal muscle
48	chr16:48115200-48116400	Enhancers	NHDF-Ad	bronchial
49	chr16:48115200-48116400	Enhancers	NHLF	lung
50	chr16:48115200-48116600	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links